BioInvent International AB (publ) (STO:BINV)
Sweden · Delayed Price · Currency is SEK 4.185
-1.245 (-22.93%)
Nov 2, 2026, 5:24 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 275.39 million as of November 2, 2026. It is the 32,378th most valuable company in the world and the 437th biggest in Sweden. Its market cap has decreased by 86.86% in one year.
Market Cap
275.39M
Enterprise Value
70.16M
Revenue
39.98M
Global Rank
Country Rank
#437 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2001, STO:BINV's market cap has decreased from 1.20B to 275.39M, a decrease of -77.14%. That is a compound annual growth rate of -5.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 275.39M | -85.77% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |
| FluoGuide | 498.65M |
| Cantargia AB | 451.68M |
| Isofol Medical AB | 383.95M |
| Sprint Bioscience AB | 379.86M |
| Corline Biomedical AB | 371.09M |
| Mendus AB | 352.63M |